Syncona Limited NPV

Our strategy is to create a diversified portfolio of 15-20 globally leading healthcare businesses companies with a goal, over a rolling 10-year basis, of delivering three to five companies in which we retain a significant ownership position to the point of product approval. We focus on developing treatments for patients by working in close partnership with world-class academic founders and management teams.